George Davis is well-known for his successes in investing, building and managing biotech, IT, and software companies, often from the start-up stage. George recently served as Partner in Gamma3 LLC, a Maryland based investment platform which provides early stage financing to locally based startups. Under George’s guidance, Gamma3 has invested in several Maryland based portfolio companies that cover a broad spectrum of life science and cybersecurity early stage opportunities. He also served as the CEO of one of Gamma3’s portfolio companies, Gemstone Biotherapeutics LLC.
With over 30 years of management experience, having served in various C-level positions, including President and CEO of publicly traded companies, George offers a broad range of experience and business acumen.